Ohls RK - Search Results

1

Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.

Bierer R, Peceny MC, Hartenberger CH, Ohls RK. Bierer R, et al. Among authors: ohls rk. Pediatrics. 2006 Sep;118(3):e635-40. doi: 10.1542/peds.2005-3186. Epub 2006 Aug 14. Pediatrics. 2006. PMID: 16908620 Clinical Trial.

2

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial.

Ohls RK, Osborne KA, Christensen RD. Ohls RK, et al. J Pediatr. 1995 Mar;126(3):421-6. doi: 10.1016/s0022-3476(95)70462-0. J Pediatr. 1995. PMID: 7869205 Clinical Trial.

3

Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration.

Brown MS, Jones MA, Ohls RK, Christensen RD. Brown MS, et al. Among authors: ohls rk. J Pediatr. 1993 Apr;122(4):655-7. doi: 10.1016/s0022-3476(05)83559-0. J Pediatr. 1993. PMID: 8463922

4

The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study.

Ohls RK, Harcum J, Schibler KR, Christensen RD. Ohls RK, et al. J Pediatr. 1997 Nov;131(5):661-5. doi: 10.1016/s0022-3476(97)70089-1. J Pediatr. 1997. PMID: 9403642 Clinical Trial.

5

Erythropoietin to prevent and treat the anemia of prematurity.

Ohls RK. Ohls RK. Curr Opin Pediatr. 1999 Apr;11(2):108-14. doi: 10.1097/00008480-199904000-00002. Curr Opin Pediatr. 1999. PMID: 10202619 Review.

6

Endothelin concentrations in preterm infants treated with human recombinant erythropoietin.

Cogar AA, Hartenberger CH, Ohls RK. Cogar AA, et al. Among authors: ohls rk. Biol Neonate. 2000 Feb;77(2):105-8. doi: 10.1159/000014203. Biol Neonate. 2000. PMID: 10657688

7

The use of erythropoietin in neonates.

Ohls RK. Ohls RK. Clin Perinatol. 2000 Sep;27(3):681-96. doi: 10.1016/s0095-5108(05)70045-2. Clin Perinatol. 2000. PMID: 10986635 Review.

8

Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.

Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, Stark AR, Shankaran S, Donovan EF, Close NC, Das A. Ohls RK, et al. Pediatrics. 2001 Oct;108(4):934-42. doi: 10.1542/peds.108.4.934. Pediatrics. 2001. PMID: 11581447 Clinical Trial.

9

Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.

Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, Delaney-Black V, Papile LA, Simon NP, Steichen JJ, Lee KG; National Institute of Child Health and Human Development Neonatal Research Network. Ohls RK, et al. Pediatrics. 2004 Nov;114(5):1287-91. doi: 10.1542/peds.2003-1129-L. Pediatrics. 2004. PMID: 15520109 Clinical Trial.

10

Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery.

Bierer R, Roohi M, Peceny C, Ohls RK. Bierer R, et al. Among authors: ohls rk. J Pediatr Surg. 2009 Aug;44(8):1540-5. doi: 10.1016/j.jpedsurg.2008.10.112. J Pediatr Surg. 2009. PMID: 19635302 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page